Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Front Public Health.
Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
Cost of screening, out-of-pocket expenditure & quality of life for diabetes & hypertension in India. Indian J Med Res.
Impact of India's publicly financed health insurance scheme on public sector district hospitals: a health financing perspective.
Effect of tobacco taxation on smoking prevalence and smoking-attributable deaths in India. Indian J Public Health.
The impact of alternate methodological and structural assumptions on results of cost-effectiveness analysis: empirical evidence using three Indian economic evaluations.
Generic ibrutinib a potential costeffective strategy for the first-line treatment of chronic lymphocytic leukaemia
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India.
India's publicly financed insurance scheme: scope for revision - authors' reply.
Universal health coverage in India and health technology assessment: current status and the way forward.